Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Chad J. Creighton, Xiaoxian Li, Melissa D. Landis, +20

Proceedings of the National Academy of Sciences

Breast OncologyImmunologyImmunoeditingPathologyBreast Cancers +14

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

Ruth Board, Andrew Wardley, J. Michael Dixon, +8

Breast Cancer Research and Treatment

Breast OncologyOncologyCancer DetectionMedicinePathology +9

Estrogen-Independent Proliferation Is Present in Estrogen-Receptor<i>HER2</i>-Positive Primary Breast Cancer After Neoadjuvant Letrozole

Matthew J. Ellis, Yu Tao, Oliver Young, +11

Journal of Clinical Oncology

Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer

J. Michael Dixon, Lorna Renshaw, Oliver Young, +7

Journal of Clinical Oncology

The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.

J. Michael Dixon, Lorna Renshaw, Christopher Bellamy, +3

PubMed

Surgical OncologyBreast OncologyTumor VolumesMedicinePharmacology +13

Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer

Elizabeth Folkerd, J. Michael Dixon, Lorna Renshaw, +2

Journal of Clinical Oncology

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

Arran Turnbull, Laura Arthur, Lorna Renshaw, +7

Journal of Clinical Oncology

Increase in response rate by prolonged treatment with neoadjuvant letrozole

J. Michael Dixon, Lorna Renshaw, E. Jane Macaskill, +6

Breast Cancer Research and Treatment

OncologyMetronomic TherapyPharmacologyTreatment OptionResponse Rate +2

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

William R. Miller, Alexey A. Larionov, Lorna Renshaw, +10

Pharmacogenetics and Genomics

Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole

William R. Miller, Alexey A. Larionov, Lorna Renshaw, +6

Journal of Clinical Oncology